Tel Aviv, Israel, September 10, 2019 --(PR.com
is a proud "Platinum" sponsor of CannX event being held today in Tel Aviv, Israel. The event has become synonymous for medical cannabis investment, start-ups, and R&D from Israel. CannX is an unparalleled event that offers organizations an opportunity to engage with senior level decision makers, build brand awareness, and launch new products to the industry.
"We are excited to take part in this year's event and showcase our expanded Provacan, our flagship CBD brand. We'll also be showing off our two recently launched brands; HuGG and Impact and showing the cannabis community what benefits can be brought to the public whilst we wait for THC regulation obstacles to be resolved," said Clifton Flack, founder and CEO of CiiTECH.
CiiTECH's Flagship brand is Provacan. Through investment in research, CiiTECH is continually developing formulas and brands to bring top quality and trustworthy products for consumers such The HuGG, a women's lifestyle brand and Impact Sports, a CBD brand for athletes and sports enthusiasts.
Catch a debate on CBD vs. THC between CiiTECH founder Clifton Flack with Ma'ayan Weisberg Joels from Tikun Olam. The Panel will take place at CannX on September 11th at 10am.
CiiTECH is a Cannabis Biotech Company that focuses on discovering, developing and commercializing cannabinoid products for the global market. We do this by partnering and collaborating with leading institutions and companies to realize the full potential of cutting-edge cannabis innovation. Our Pathway is to develop a pipeline of collaborative research between leading Israeli and UK institutions. The results and insights from this research guide our brand and product development.
CannX is the leading international conference in medical cannabis. The conference is held in partnership with Cann10, the trusted global partner for medical cannabis investment, start-ups, R&D, growth, trade know-how and education.